MicroSectors FANG & Innovation 3x Leveraged ETN financials
$42.24−7.12%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Oct 31 | FY24 Oct 31 | FY23 Oct 31 | FY22 Oct 31 | FY21 Oct 31 |
|---|---|---|---|---|---|
| Revenue | $55.74B | $56.92B | $47.67B | $32.85B | $26.46B |
| Gross profit | $25.81B | $23.54B | $21.08B | $24.76B | $21.95B |
| Gross margin | 46.3% | 41.3% | 44.2% | 75.4% | 83.0% |
| Operating income | $8.22B | $6.84B | $4.29B | $13.14B | $8.28B |
| Net income | $5.89B | $4.97B | $2.95B | $9.77B | $6.06B |
| Net margin | 10.6% | 8.7% | 6.2% | 29.8% | 22.9% |
| Diluted EPS | $162.82 | $136.50 | $83.01 | $2936.66 | $1870.28 |
| EBITDA | $8.22B | $6.84B | $4.29B | $13.14B | $8.28B |
| Operating cash flow | $7.29B | $19.16B | $6.91B | $3.64B | $35.57B |
| Free cash flow | $6.06B | $18.04B | $5.70B | $3.07B | $35.18B |
| Diluted shares | 36.2M | 36.4M | 35.5M | 3.3M | 3.2M |
Balance sheet
| Period end | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $48.02B | $46.72B | $56.16B | $64.25B | $75.31B |
| Short-term investments | $395.47B | $367.03B | $316.96B | $288.08B | $281.46B |
| Total debt | $42.74B | $34.84B | $25.45B | $25.87B | $26.15B |
| Total assets | $1.05T | $1.01T | $970.66B | $836.78B | $798.00B |
| Total liabilities | $988.22B | $951.17B | $915.81B | $784.60B | $751.55B |
| Shareholders' equity | $62.69B | $60.49B | $54.85B | $52.18B | $46.45B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology